7 Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism.
http://www.nejm.org/doi/full/10.1056/NEJMoa1306638
6 High levels of CD34+CD38low/−CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang (GOELAMS) study.
http://www.haematologica.org/content/96/12/1792.abstract
5 The NOTCH pathway contributes to cell fate decision in myelopoiesis.
http://www.haematologica.org/content/96/12/1753.abstract
4 From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.
http://bloodjournal.hematologylibrary.org/content/118/24/6258.abstract
3 Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors.
http://bloodjournal.hematologylibrary.org/content/118/24/6368.abstract
2 Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
http://bloodjournal.hematologylibrary.org/content/118/24/6284.abstract
1 Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
http://bloodjournal.hematologylibrary.org/content/118/24/6310.abstract
|